Immunotherapy of lymphoma and leukemia with T-cell engaging BiTE antibody blinatumomab (Q34981971)

5 August 2017

1 reference

title

Immunotherapy of lymphoma and leukemia with T-cell engaging BiTE antibody blinatumomab (English)

1 reference

5 August 2017

1 reference

1 reference

1 reference

5

Patrick A Baeuerle

1 reference

5 August 2017

Dirk Nagorsen

1

1 reference

5 August 2017

Ralf Bargou

2

1 reference

5 August 2017

Dominik Ruttinger

3

1 reference

5 August 2017

Peter Kufer

4

1 reference

5 August 2017

Gerhard Zugmaier

6

1 reference

5 August 2017

1 June 2009

1 reference

5 August 2017

1 reference

5 August 2017

50

1 reference

5 August 2017

6

1 reference

5 August 2017

886-891

1 reference

Immune surveillance of tumors

5 August 2017

1 reference

https://api.crossref.org/works/10.1080%2F10428190902943077

CD8+ T-cell content in diagnostic lymph nodes measured by flow cytometry is a predictor of survival in follicular lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190902943077

Type, density, and location of immune cells within human colorectal tumors predict clinical outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190902943077

Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190902943077

Adoptive cell therapy for patients with metastatic melanoma: evaluation of intensive myeloablative chemoradiation preparative regimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190902943077

Tumor microenvironment and immune escape

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190902943077

Immunosuppressive strategies that are mediated by tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190902943077

Differences in T-cell immunity toward tumor-associated antigens in colorectal cancer and breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190902943077

T cell responses against tumor associated antigens and prognosis in colorectal cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190902943077

T-cell activation and B-cell depletion in chimpanzees treated with a bispecific anti-CD19/anti-CD3 single-chain antibody construct

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190902943077

Induction of regular cytolytic T cell synapses by bispecific single-chain antibody constructs on MHC class I-negative tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190902943077

Tumor regression in cancer patients by very low doses of a T cell-engaging antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190902943077

10.1080/10428190902943077

21 January 2018

Identifiers

DOI

1 reference

5 August 2017

1 reference